Geneos Wealth Management’s CAVA Group CAVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$262K Buy
3,340
+20
+0.6% +$1.68K 0.01% 910
2026
Q1
$269K Hold
3,320
0.01% 866
2025
Q4
$195K Buy
3,320
+1,500
+82% +$83.6K ﹤0.01% 938
2025
Q3
$110K Buy
1,820
+732
+67% +$55.5K ﹤0.01% 1090
2025
Q2
$91.6K Buy
1,088
+509
+88% +$43.4K ﹤0.01% 1287
2025
Q1
$50K Buy
579
+18
+3% +$1.95K ﹤0.01% 1471
2024
Q4
$63.3K Buy
+561
New +$74.8K ﹤0.01% 1228

Other funds holding CAVA

Geneos Wealth Management's CAVA Position: Q2 2026 in Review

Geneos Wealth Management increased its CAVA Group (CAVA) stake by 0.6% in Q2 2026, buying an estimated $1.68K and bringing the position to 3,340 shares worth $262K. The position accounts for 0.01% of the portfolio, ranked #910.

Geneos Wealth Management first reported a position in CAVA in Q4 2024 and has held it in 7 quarters since. The position peaked at $269K in Q1 2026. 538 funds tracked by Wall St. Rank hold CAVA as of Q2 2026.

  • Geneos Wealth Management held 3,340 shares of CAVA Group worth $262K as of Q2 2026.
  • Geneos Wealth Management bought 20 CAVA Group shares in Q2 2026, an estimated $1.68K.
  • CAVA Group made up 0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #910 holding.
  • Geneos Wealth Management first reported a position in CAVA Group in Q4 2024 and has held it in 7 quarters since.
  • Geneos Wealth Management's CAVA Group position peaked at $269K in Q1 2026.
  • 538 funds tracked by Wall St. Rank held CAVA Group as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.